-
1 week ago | 
law360.com | David Munkittrick |Michael Beckwith
By David Munkittrick and Michael Beckwith ( April 11, 2025, 5:23 PM EDT) -- This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss the antitrust implications and regulation of synthetic data.... Law360 is on it, so you are, too.
-
1 week ago | 
law360.co.uk | David Munkittrick |Michael Beckwith
ADVERTISEMENT Don't want ads? Subscribe or login now. By David Munkittrick and Michael Beckwith ( April 11, 2025, 5:23 PM EDT) -- This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss the antitrust implications and regulation of synthetic data....
-
Nov 25, 2024 | 
jdsupra.com | David Munkittrick
This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss what the election means for the FTC's focus on labor markets. Under Chair Lina Khan, the Federal Trade Commission elevated its focus on labor markets. It promulgated a rule attempting to ban noncompete agreements, now stayed and subject to litigation.
-
Nov 21, 2024 | 
law360.com | David Munkittrick
By Kelly Landers Hawthorne and David Munkittrick ( November 21, 2024, 4:12 PM EST) -- This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss what the election means for the FTC's focus on labor markets.... Law360 is on it, so you are, too.
-
Nov 21, 2024 | 
law360.co.uk | David Munkittrick
Hello! I'm Law360's automated support bot. How can I help you today? For example, you can type: I forgot my password I took a free trial but didn't get a verification email How do I sign up for a newsletter?
-
Nov 7, 2024 | 
jdsupra.com | Peter Angelica |David Munkittrick
The Department of Justice and eight state attorneys general filed a civil antitrust lawsuit in August against RealPage Inc. – a Texas-based software company that provides property management software – and several landlords using its software. This case adds to the growing number of antitrust cases targeting algorithmic pricing tools, and is another example of federal regulators taking a tough stance on new AI technologies.
-
Nov 6, 2024 | 
natlawreview.com | David Munkittrick |Susan Gross Sholinsky |Michael Ferrell |Yuki Sako
On November 4, 2024, the European Data Protection Board (“EDPB”) adopted its first report (the “Report”) under the EU-U.S. Data Privacy Framework (“DPF”), welcoming the efforts made by U.S. authorities and the European Commission to implement the DPF. The Report follows the EDPB’s review of the European Commission’s adequacy decision for the DPF, which is required by Article 3 of the decision.
-
Nov 6, 2024 | 
natlawreview.com | David Munkittrick
The Department of Justice and eight state attorneys general filed a civil antitrust lawsuit in August against RealPage Inc. – a Texas-based software company that provides property management software – and several landlords using its software. This case adds to the growing number of antitrust cases targeting algorithmic pricing tools, and is another example of federal regulators taking a tough stance on new AI technologies.
-
Nov 6, 2024 | 
mindingyourbusinesslitigation.com | David Munkittrick |Peter Angelica
Kelly Landers Hawthorne is an associate in the Litigation Department and a member of the Antitrust and Mass Torts & Product Liability Groups. She represents clients in litigations and due diligence across a range of industries, including consumer products, life sciences, healthcare, education, hospitality, sports and entertainment. Kelly also maintains a diverse pro bono practice. She received Proskauer’s Golden Gavel Award for excellence in pro bono work in 2019.
-
Oct 4, 2024 | 
mondaq.com | Erica Jones |Peter Angelica |David Munkittrick
This article is part of a monthly column that considers the
significance of recent Federal Trade Commission announcements about
antitrust issues. In this installment, we discuss the FTC's
complaint on PBMs' conduct around insulin.
No stranger to controversy about their role in pharmaceutical
pricing, pharmacy benefit managers are headed for more.
On Sept.
